Related references
Note: Only part of the references are listed.Murine Hematopoietic Cell Tissue Factor Pathway Inhibitor Limits Thrombus Growth
Susan A. Maroney et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
In Vivo Fluorescence Imaging of Large-Vessel Thrombosis in Mice
Brian C. Cooley
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
Emily K. Waters et al.
BLOOD (2011)
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases
Steffen Massberg et al.
NATURE MEDICINE (2010)
Alternatively spliced isoforms of tissue factor pathway inhibitor
Susan A. Maroney et al.
THROMBOSIS RESEARCH (2010)
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice
S. A. Maroney et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A
Srinivasa Prasad et al.
BLOOD (2008)
Active tissue factor pathway inhibitor is expressed on the surface of coated platelets
Susan A. Maroney et al.
BLOOD (2007)
A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice
B Pedersen et al.
BLOOD (2005)
Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A
I Hrachovinová et al.
NATURE MEDICINE (2003)
Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and Factor V Leiden
DT Eitzman et al.
CIRCULATION (2002)
Regulation of monocyte procoagulant activity in acute myocardial infarction:: role of tissue factor and tissue factor pathway inhibitor-1
I Ott et al.
BLOOD (2001)